SIGY Sigyn Therapeutics, Inc.

Fundamentals / CIK 0001642159 / USD

Sigyn Therapeutics, Inc. reported $136K in total assets and a net loss of $3.22M through December 31, 2024 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SIGY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2014 to 2024), reported in USD.

$590K$295K$0-$3.99MFY 2014 Revenue: $43KFY 2014 Net Income: -$388K2014FY 2015 Revenue: $29KFY 2015 Net Income: -$2.69M2015FY 2017 Revenue: $38KFY 2017 Net Income: -$4.25M2017FY 2018 Revenue: $28KFY 2018 Net Income: -$2.62M2018FY 2019 Revenue: $143KFY 2019 Net Income: -$3.07M2019FY 2020 Net Income: -$1.26M2020FY 2021 Net Income: -$3.00M2021FY 2022 Net Income: -$2.93M2022FY 2023 Net Income: -$4.15M2023FY 2024 Net Income: -$3.34M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- $143K $28K $38K $29K $43K
Cost of Revenue -- -- -- -- -- $36K $9.7K $21K $9.9K $25K
Gross Profit -- -- -- -- -- $108K $19K $17K $19K $18K
Research & Development $773K $798K $658K $734K $419K -- -- -- -- --
Total Operating Expenses $2.52M $2.46M $2.15M $2.01M $916K $626K $1.02M $2.05M $2.27M $405K
Operating Income -$2.52M -$2.46M -$2.15M -$2.01M -$916K -$518K -$1.00M -$2.03M -$2.25M -$388K
EBITDA -$2.51M -$2.45M -$2.14M -$1.99M -$905K -$443K -$757K -$1.79M -$2.25M --
Interest Expense -- -- -- $31K $343K $55K $353K $791K -$441K --
Income Before Tax -$3.34M -$4.15M -$2.93M -$3.00M -$1.26M -$3.31M -$2.30M -$3.84M -$2.69M -$388K
Income Tax Expense -- -- -- -- -- -- $800 $800 -- --
Net Income -$3.34M -$4.15M -$2.93M -$3.00M -$1.26M -$3.07M -$2.62M -$4.25M -$2.69M -$388K
Basic EPS -$2.51 -$3.77 -$3.13 -$3.20 -$6.80 -$1.60 -$1.60 -$3.60 -$3.60 -$0.40
Diluted EPS -$2.51 -$3.77 -$3.13 -$3.20 -$6.80 -$1.60 -$1.60 -$3.60 -$3.60 -$0.40
Basic Shares Outstanding 1.3M 1.1M 934.9K 909.9K 183.8K 2.0M 1.6M 1.2M 774.8K 698.8K
Diluted Shares Outstanding 1.3M 1.1M 934.9K 909.9K 183.8K 2.0M 1.6M 1.2M 774.8K 698.8K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Research & Development $30K $7.5K $8.8K $94K $206K $240K $233K $216K
Total Operating Expenses $387K $470K $546K $478K $808K $603K $630K $717K
Operating Income -$387K -$470K -$546K -$478K -$808K -$603K -$630K -$717K
EBITDA -$387K -$470K -$545K -$477K -$807K -$601K -$628K -$716K
Income Before Tax -$579K -$1.45M -$669K -$523K -$1.20M -$862K -$758K -$1.18M
Net Income -$579K -$1.45M -$669K -$523K -$1.20M -$862K -$758K -$1.18M
Basic EPS -$0.36 -$0.90 -$0.42 -- -$0.94 -$0.70 -$0.62 --
Diluted EPS -$0.36 -$0.90 -$0.42 -- -$0.94 -$0.70 -$0.62 --
Basic Shares Outstanding 1.6M 1.6M 1.6M -- 1.3M 1.2M 1.2M --
Diluted Shares Outstanding 1.6M 1.6M 1.6M -- 1.3M 1.2M 1.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $12K $12K $8.4K $341K $84K $500 $7.5K $9.6K $639K $95
Cash & Short-Term Investments $12K $12K $8.4K $341K $84K $500 $7.5K $9.6K $639K $95
Accounts Receivable, Net -- -- -- -- -- -- -- $9.7K -- $9.4K
Inventory -- $50K $50K $50K $586K $588K $724K $726K $510K $423K
Other Current Assets $9.1K $56K $12K $2.1K -- -- -- -- -- --
Total Current Assets $21K $118K $70K $393K $670K $589K $733K $761K $1.16M $484K
Property, Plant & Equipment, Net $9.7K $15K $22K $28K $1.7K $3.1K $16K $25K $4.8K $3.5K
Goodwill -- -- -- -- -- -- -- $482K -- --
Intangible Assets -- -- $2.1K $5.7K $22K $50K $113K $179K $260K --
Other Non-Current Assets $71K $21K $21K $21K -- -- -- -- -- --
Total Non-Current Assets $192K $204K $263K $317K $24K -$589K $129K $1.31M $265K $78K
Total Assets $214K $322K $333K $710K $694K $0 $862K $2.07M $1.43M $562K
Accounts Payable $608K $462K $328K $40K $16K $910 $23K $73K $20K --
Short-Term Debt $174K -- -- -- -- -- -- -- -- --
Deferred Revenue (Current) -- -- -- -- -- -- -- $81K -- --
Other Current Liabilities $1.7K $3.2K $1.2K $179 $523 $27K $70K $54K -- --
Total Current Liabilities $4.61M $3.61M $2.05M $734K $595K $910 $4.58M $4.16M $1.50M $463K
Long-Term Debt $2.02M $2.51M $2.28M -- -- -- -- -- -- --
Total Non-Current Liabilities $56K $126K $187K $241K $0 $0 $0 $0 $13K $0
Total Liabilities $4.67M $3.73M $2.24M $975K $595K $910 $4.58M $4.16M $1.51M $463K
Total Debt (incl. Leases) $2.32M $2.70M $2.52M $287K -- -- -- -- -- --
Common Stock $161 $129 $96 $3.7K $3.5K $50 $8.1K $5.3K $3.4K $3.0K
Retained Earnings -$14.68M -$11.34M -$7.20M -$4.27M -$1.26M -$1.6K -$13.00M -$10.38M -$3.33M -$632K
Total Stockholders' Equity -$4.46M -$3.41M -$1.90M -$265K $99K -$910 -$3.72M -$2.09M -$82K $99K
Total Equity -$4.46M -$3.41M -$1.90M -$265K $99K -$910 -$3.72M -$2.09M -$82K $99K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Cash & Cash Equivalents $86K $459 $13K $12K $165K $54K $33K $12K
Cash & Short-Term Investments $86K $459 $13K $12K $165K $54K $33K $12K
Inventory -- -- -- -- $50K $50K $50K $50K
Other Current Assets -- $1.3K $55K $9.1K $54K $43K $52K $56K
Total Current Assets $86K $1.8K $68K $21K $269K $146K $134K $118K
Property, Plant & Equipment, Net -- -- $8.3K $9.7K $11K $12K $14K $15K
Other Non-Current Assets $50K $50K $71K $71K $21K $21K $21K $21K
Total Non-Current Assets $50K $50K $176K $192K $158K $174K $189K $204K
Total Assets $136K $52K $244K $214K $427K $320K $323K $322K
Accounts Payable $774K $730K $672K $608K $612K $488K $529K $462K
Short-Term Debt $1.03M $262K $213K $174K -- -- -- --
Other Current Liabilities $3.9K $3.4K $312 $1.7K $48 $2.2K $2.6K $3.2K
Total Current Liabilities $3.99M $5.49M $5.15M $4.61M $4.28M $3.90M $4.23M $3.61M
Long-Term Debt $2.83M -- -- $2.02M $2.00M $2.01M $2.78M $2.51M
Total Non-Current Liabilities $2.06M $0 $38K $56K $75K $93K $110K $126K
Total Liabilities $6.05M $5.49M $5.19M $4.67M $4.35M $3.99M $4.34M $3.73M
Total Debt (incl. Leases) $3.85M $262K $323K $2.32M $2.14M $2.17M $2.96M $2.70M
Common Stock $161 $161 $161 $161 $142 $126 $122 $129
Retained Earnings -$17.38M -$16.80M -$15.35M -$14.68M -$14.16M -$12.96M -$12.10M -$11.34M
Total Stockholders' Equity -$5.92M -$5.44M -$4.95M -$4.46M -$3.92M -$3.67M -$4.02M -$3.41M
Total Equity -$5.92M -$5.44M -$4.95M -$4.46M -$3.92M -$3.67M -$4.02M -$3.41M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$3.34M -$4.15M -$2.93M -$3.00M -$1.26M -$3.07M -$2.62M -$4.25M -$2.69M -$388K
Depreciation & Amortization $5.6K $8.9K $10K $19K $11K $75K $247K $236K $1.2K --
Stock-Based Compensation $150K $216K -- -- $0 -- $115K $920K -- --
Change in Receivables -- -- -- -- -- -- $7.6K -$9.7K -$29K -$1.0K
Change in Inventory -- -- -- -- -- $135K $2.5K -$2.5K $9.9K $25K
Change in Payables $147K $197K $288K $24K $15K -$12K -$139K $177K -- --
Operating Cash Flow -$872K -$1.38M -$1.83M -$1.77M -$830K -$144K -$286K -$400K -$84K -$44K
Capital Expenditure -- -- -$860 -$29K -- -- -$3.0K -$940 -$2.5K -$3.5K
Free Cash Flow -- -- -$1.83M -$1.80M -- -- -$289K -$401K -$86K -$48K
Investing Cash Flow -- -- -$860 -$29K -$11K $100K -$8.5K -$79K -$12K -$3.5K
Common Stock Issued -- -- -- $1.86M -- -- -- -- -- --
Financing Cash Flow $873K $1.39M $1.50M $2.06M $925K $37K $292K $339K $735K $48K
Net Change in Cash $454 $3.3K -$333K $257K $84K -$7.0K -$2.1K -$140K $639K $95

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Net Income -$579K -$1.45M -$669K -$523K -$1.20M -$862K -$758K -$1.18M
Depreciation & Amortization $0 $0 $1.4K $1.4K $1.4K $1.4K $1.5K $1.6K
Stock-Based Compensation $50K $50K $50K $38K $38K $38K $38K $103K
Change in Payables $44K $58K $64K -$3.3K $123K -$41K $68K $163K
Operating Cash Flow -$199K -$152K -$294K -$290K -$164K -$183K -$236K -$128K
Financing Cash Flow $284K $140K $295K $138K $275K $204K $257K $75K
Net Change in Cash $85K -$12K $751 -$153K $111K $21K $21K -$53K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- 75.1% 65.7% 44.2% 66.0% 41.5%
Operating Margin -- -- -- -- -- -361.4% -3544.2% -5277.4% -7714.3% -898.0%
Net Profit Margin -- -- -- -- -- -2145.3% -9243.2% -11061.2% -9224.9% -898.0%
Return on Equity (ROE) -- -- -- -- -1270.0% -- -- -- -- -389.8%
Return on Assets (ROA) -1562.9% -1288.3% -880.1% -423.0% -181.5% -- -304.0% -205.3% -188.8% -68.9%
Current Ratio 0.00x 0.03x 0.03x 0.54x 1.13x 646.82x 0.16x 0.18x 0.78x 1.05x
Quick Ratio 0.00x 0.02x 0.01x 0.47x 0.14x 0.55x 0.00x 0.01x 0.44x 0.13x
Revenue Growth (YoY) -- -- -- -- -- +405.6% -26.2% -- -32.3% --
Gross Profit Growth (YoY) -- -- -- -- -- +477.7% +9.6% -- +7.7% --
5Y Revenue / Share Growth -- -- -- -- -- +14.2% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Return on Assets (ROA) -2375.9% -7418.0% -1330.6% -1562.9% -934.3% -1156.4% -1102.1% -1288.3%
Current Ratio 0.02x 0.00x 0.01x 0.00x 0.06x 0.04x 0.03x 0.03x
Quick Ratio 0.02x 0.00x 0.00x 0.00x 0.05x 0.02x 0.02x 0.02x
Source: SEC EDGAR CompanyFacts (CIK 0001642159) · from September 30, 2014 Data through September 30, 2025 · synced Nov 21, 2026, 05:15 UTC · Open in terminal